Plus, get the best of BroadwayWorld delivered to your inbox, and unlimited access to our editorial content across the globe. The University of Arizona's School of Theatre, Film & Television (TFTV) ...
The School of Theatre, Film & Television will present the New Directions Festival, featuring new plays by emerging playwrights centered on themes of brokenness. The event aims to highlight fresh ...
COPENHAGEN, Denmark--(BUSINESS WIRE)-- Genmab A/S (Nasdaq: GMAB) and Pfizer, Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has accepted the supplemental Biologics ...
Please provide your email address to receive an email when new articles are posted on . Tisotumab vedotin-tftv prolonged OS compared with chemotherapy alone among women with recurrent or metastatic ...
TIVDAK (tisotumab vedotin-tftv) is an antibody-drug conjugate (ADC) composed of Genmab’s human monoclonal antibody directed to tissue factor (TF) and Pfizer’s ADC technology that utilizes a ...
COPENHAGEN, Denmark & BOTHELL, Wash.--(BUSINESS WIRE)--Genmab A/S (Nasdaq: GMAB) and Seagen Inc. (Nasdaq: SGEN) announced today that the Phase 3 innovaTV 301 global trial in recurrent or metastatic ...
TIVDAK (tisotumab vedotin-tftv) is an ADC composed of Genmab’s human monoclonal antibody directed to tissue factor (TF) and Seagen’s ADC technology that utilizes a protease-cleavable linker that ...
-- Zai Lab Obtains Exclusive Rights to Develop and Commercialize TIVDAK, an FDA-approved First-in-Class Antibody-Drug Conjugate (ADC), in Mainland China, Hong Kong, Macau, and Taiwan-- -- Zai Lab will ...
Submission based on positive results from global phase 3 innovaTV 301 trial demonstrating overall survival benefit of tisotumab vedotin-tftv over chemotherapy The sBLA is supported by efficacy and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results